https://www.fda.gov/industry/generic-drug-user-fee-amendments/gdufa-ii-drug-master-file-dmf-review-enhancements
GDUFA II Drug Master File (DMF) Review Enhancements | FDA
Effective communication between ANDA holders, DMF suppliers, and FDA is essential for reducing the likelihood of potential problems that could delay approvals.
drug master fileiidmfreviewenhancements
https://www.fda.gov/drugs/news-events-human-drugs/drug-master-file-dmf-submissions-new-fda-form-3938-01132021
Drug Master File (DMF) Submissions on New FDA Form 3938 - 01/13/2021 | FDA
Drug Master File (DMF) Submissions on New FDA Form 3938
drug master file
https://www.fda.gov/drugs/drug-master-files-dmfs/fda-ind-nda-anda-or-drug-master-file-binders
FDA IND, NDA, ANDA, or Drug Master File Binders | FDA
Binders (covers) can be ordered on line from the U.S. Government Printing Office (GPO) Web site: https://bookstore.gpo.gov/ by searching for the appropriate...
drug master filefdaindnda
https://www.fda.gov/drugs/drug-master-files-dmfs/drug-master-file-dmf-submission-resources
Drug Master File (DMF) Submission Resources | FDA
Here are some additional resources for how to prepare and submit DMFs.
drug master filesubmission resourcesdmffda
https://www.prnewswire.com/news-releases/shine-technologies-llc-announces-submission-of-fda-drug-master-file-for-non-carrier-added-lutetium-177-302109642.html
SHINE Technologies, LLC Announces Submission of FDA Drug Master File for Non-Carrier-Added...
/PRNewswire/ -- SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, becomes North America's largest producer of...